TechNavio today launched its report, Global Ophthalmic Drugs Market 2011-2015, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”There is an increase in the use of fixed-combination therapies for the treatment of glaucoma. Combination therapies significantly improve compliance by reducing the number and frequency of eye drop applications. The vendors in the Global Ophthalmic Drugs market are focusing more on the development of combination therapies. This is evident from the strong pipeline of combination therapies. Combination therapies are expected to reduce inflammation, the possibility of choroidal neovascularization, and vascular endothelial growth factor (VEGF) expression.”
According to the report, one of the key drivers is the increasing prevalence of eye disorders such as macular degeneration, diabetic retinopathy (DR), and presbyopia in the elderly population. Moreover, incidences of glaucoma and cataracts are increasing every year. Massive numbers of people worldwide suffer from glaucoma, and this number is expected to further increase by 2020. Across the globe, many people are estimated to suffer from age-related macular degeneration (AMD). The incidence of AMD is expected to increase significantly during the forecast period.
Further, the report reveals that one of the key challenges in this market is low patient compliance.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-ophthalmic-drugs-market-2011-2015
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Ophthalmic Drugs Market 2011-2015
